多发性硬化患者手动萎缩测量的验证研究
研究纳入58例临床孤立综合征、48例接受干扰素β治疗和26例接受那他珠单抗治疗的多发性硬化患者,基线和1年后行脑MRI,由两名观察者用Jim v.6.0手动测量胼胝体指数、归一化胼胝体面积和第三脑室宽度,并与体积测量和EDSS比较。结果显示归一化胼胝体面积与胼胝体体积、第三脑室宽度与第三脑室体积相关性很好(r=0.85、r=0.83;p<0.01),第三脑室宽度和归一化胼胝体面积似乎是与体积测量和EDSS相关性更稳健的手动测量指标。
要点
- 归一化胼胝体面积与胼胝体体积相关性很好(r=0.85,p<0.01)。
- 第三脑室宽度与第三脑室体积相关性很好(r=0.83,p<0.01)。
- 第三脑室宽度和归一化胼胝体面积似乎是与体积测量和EDSS相关性更稳健的手动测量指标。
核心结论
- 第三脑室宽度和归一化胼胝体面积似乎是与体积测量和EDSS相关性更稳健的手动测量指标,尤其在疾病更进展的患者中。
研究设计与样本
- 研究纳入58例临床孤立综合征、48例接受干扰素β治疗的多发性硬化患者和26例接受那他珠单抗治疗的多发性硬化患者,基线和1年后行脑MRI。
- 由两名观察者在两个时间点使用Jim v.6.0进行手动测量。
- 使用SIENA/x和Freesurfer计算归一化脑体积、脑实质分数、年化脑体积变化百分比、胼胝体体积、脑室体积和第三脑室体积;统计分析使用SPSS v.13。
诊断标准与关键数值
- 归一化胼胝体面积与胼胝体体积相关性很好(r=0.85,p<0.01)。
- 第三脑室宽度与第三脑室体积相关性很好(r=0.83,p<0.01)。
- 第三脑室宽度、胼胝体指数和归一化胼胝体面积与全部患者的EDSS相关性显著。
- 在那他珠单抗治疗患者中,第三脑室宽度与归一化脑体积和脑实质分数呈中度至强相关(分别为r=-0.54、r=-0.61;p<0.05)。
- 在那他珠单抗治疗患者中,归一化胼胝体面积与归一化脑体积和脑实质分数呈中度至强相关(分别为r=0.55、r=0.67;p<0.05)。
临床应用与阅片要点
- 原文结论指出第三脑室宽度和归一化胼胝体面积似乎是与体积测量和EDSS相关性更稳健的手动测量指标,尤其在疾病更进展的患者中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Manual measures such as corpus callosum index, normalized corpus callosum area, and width of the third ventricle are potential biomarkers for brain atrophy. In this work, we investigate their suitability to assess the neurodegenerative component of multiple sclerosis (MS) by comparing them to volumetric measures and expanded disability status scale (EDSS).
METHODS: Fifty-eight patients with a clinically isolated syndrome, 48 MS patients treated with interferon β, and 26 treated with natalizumab underwent a brain MRI at baseline and after 1 year. Manual measures were evaluated by two observers using Jim v.6.0 at both time points. Volumetric tools (SIENA/x and Freesurfer) were used to calculate normalized brain volume, brain parenchymal fraction, annualized percentage of brain volume change, corpus callosum volume, ventricle volume, and volume of the third ventricle. Statistical analyses were performed with SPSS v.13.
RESULTS: Usage of corpus callosum volume and third ventricle volume to validate normalized corpus callosum area and width of the third ventricle, respectively, showed very good correlations (r = 0.85, r = 0.83; p < 0.01). Width of the third ventricle, corpus callosum index, and normalized corpus callosum area correlations were significant with EDSS in all patients and moderate to strong with normalized brain volume and brain parenchymal fraction in natalizumab-treated patients (respectively r = - 0.54, r = - 0.61; r = 0.55, r = 0.67; and r = 0.58, r = 0.67; with p < 0.05).
CONCLUSION: Width of the third ventricle and normalized corpus callosum area seem the more robust manual measures regarding correlation with volumetric measures and EDSS, especially in patients with more advanced disease.
引用
- Cappelle S, Pareto D, Tintoré M, et al. A validation study of manual atrophy measures in patients with Multiple Sclerosis. Neuroradiology. 2020. PMID: 32246177. doi:10.1007/s00234-020-02401-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。